Asset Allocation & Management Company’s Gilead Sciences GILD Stock Holding History

Asset Allocation & Management Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,803	Closed	-$316K	–	77
2023 Q1	$316K	Hold	3,803	–	–	0.13%	76
2022 Q4	$326K	Sell	3,803 -1,445	-28%	-$114K	0.13%	85
2022 Q3	$324K	Hold	5,248	–	–	0.13%	84
2022 Q2	$324K	Sell	5,248 -7,872	-60%	-$487K	0.14%	95
2022 Q1	$780K	Hold	13,120	–	–	0.28%	75
2021 Q4	$953K	Buy	+13,120	New	+$904K	0.32%	65

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Asset Allocation & Management Company's GILD Position: Q2 2023 in Review

Asset Allocation & Management Company sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 3,803 shares — an estimated $316K sold.

Asset Allocation & Management Company first reported a position in GILD in Q4 2021 and held it in 6 quarters. The position peaked at $953K in Q4 2021. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

Asset Allocation & Management Company reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
Asset Allocation & Management Company sold 3,803 Gilead Sciences shares in Q2 2023, an estimated $316K.
Asset Allocation & Management Company first reported a position in Gilead Sciences in Q4 2021 and held it in 6 quarters.
Asset Allocation & Management Company's Gilead Sciences position peaked at $953K in Q4 2021.
1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Asset Allocation & Management Company's 13F filing for Q2 2023, filed 8 Aug 2023.